News Focus
News Focus
Post# of 257266
Next 10
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

Re: ThomasS post# 150675

Tuesday, 10/16/2012 9:00:15 AM

Tuesday, October 16, 2012 9:00:15 AM

Post# of 257266

ABT: having cured 52 of 53 GT1a and 24 of 24 GT1b, ABT has already addressed the lion's share of difficult to treat HCV patients.




The SVR rates were terrific and this puts pressure on GILD.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today